Tamiflu US Press Conference

09:53 EDT 9 Apr 2014 | British Medical Journal

Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported. Here is the audio...

Original Article: Tamiflu US Press Conference


More From BioPortfolio on "Tamiflu US Press Conference"

Quick Search

Relevant Topic

Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...